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Summary
Toxoplasma gondii parasites rapidly exit their host 
cell when exposed to calcium ionophores. Calcium-
dependent protein kinase 3 (TgCDPK3) was previ-
ously identified as a key mediator in this process, as 
TgCDPK3 knockout (∆cdpk3) parasites fail to egress 
in a timely manner. Phosphoproteomic analysis 
comparing WT with ∆cdpk3 parasites revealed 
changes in the TgCDPK3-dependent phosphopro-
teome that included proteins important for regulat-
ing motility, but also metabolic enzymes, indicating 
that TgCDPK3 controls processes beyond egress. 
Here we have investigated a predicted direct target 
of TgCDPK3, ApiAT5-3, a putative transporter of the 
major facilitator superfamily, and show that it is rap-
idly phosphorylated at serine 56 after induction of 
calcium signalling. Conditional knockout of apiAT5-3 
results in transcriptional upregulation of most ribo-
somal subunits, but no alternative transporters, and 
subsequent parasite death. Mutating the S56 to a 
non-phosphorylatable alanine leads to a fitness 
cost, suggesting that phosphorylation of this resi-
due is beneficial, albeit not essential, for tyrosine 
import. Using a combination of metabolomics and 
heterologous expression, we confirmed a primary 
role in tyrosine import for ApiAT5-3. However, no 
significant differences in tyrosine import could be 
detected in phosphorylation site mutants showing 
that if tyrosine transport is affected by S56 phospho-
rylation, its regulatory role is subtle.
Introduction
The fast-growing tachyzoite stage of the protozoan par-
asite Toxoplasma gondii requires cycles of host cell 
invasion, replication and lysis for its successful prolifera-
tion within the host. Each step of this lytic cycle involves 
tightly regulated signalling pathways, the intricacies of 
which remain largely unknown. Paramount to parasite 
survival is the ability to sense and respond to changes in 
the environment for which the divalent calcium ion (Ca2+) 
acts as an important secondary messenger (Lourido 
and Moreno, 2015). Changes in free intracellular [Ca2+]i 
levels, via release of Ca2+ from organellar Ca2+ stores, 
can be induced by the addition of Ca2+ ionophores, such 
as A23187 or phosphodiesterase inhibitors (Sidik, Hortua 
Triana, et al., 2016; Stewart et al., 2016). Ca2+ flux regulates 
key processes including secretion of micronemes prior 
to host cell entry (Carruthers and Sibley, 1999), parasite 
motility (Wetzel et al., 2004), and host cell egress (Endo et 
al., 1982) and invasion (Lovett and Sibley, 2003). Inversely, 
these processes can all be inhibited by Ca2+ immobilisers 
or chelators, such as BAPTA-AM (Mondragon and Frixione, 
1996; Black et al., 2000; Moudy et al., 2001; Wetzel et al., 
2004). Ca2+ release leads to the activation of Ca2+-binding 
proteins such as calmodulins, calcineurin B-like kinases 
and calcium-dependent protein kinases (CDPKs). T. gon-
dii calcium-dependent protein kinase 3 (TgCDPK3), for 
example, has been implicated in the regulation of iono-
phore-induced egress, IIE (i.e. the rapid exit of tachyzoites 
from a host cell on addition of ionophore) and ionophore-in-
duced death, IID (i.e. the loss of infectivity of extracellular 
 parasites after prolonged exposure to ionophore) (Black 
et al., 2000). TgCDPK3 KO (∆cdpk3) (McCoy et al., 2012), 
mutants (Black et al., 2000) and chemically inhibited 
TgCDPK3 lines (Lourido v., 2012) all show a deficiency in 
IIE and IID. TgCDPK3 is a serine/threonine kinase belong-
ing to a large family of CDPKs also found in plants and 
ciliates, but absent in humans. It is anchored to the para-
site plasma membrane, via N-terminal myristoylation and 
palmitoylation motifs (Garrison et al., 2012; Lourido et al., Accepted 20 October, 2018. *For correspondence. E-mail Moritz.treeck@crick.ac.uk; Tel. +44 20 3796 2345.
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2012; McCoy et al., 2012), facing the lumen of the para-
site. Like all CDPKs, TgCDPK3 possesses a C-terminal 
calmodulin-like domain that consists of EF hands, known 
as the CDPK activation domain, as well as upstream auto-
inhibitory and catalytic domains (Huang et al., 1996; Billker 
et al., 2009). Binding of Ca2+ to the EF hands causes a 
structural rearrangement that frees up the active site of 
the kinase domain, allowing for substrate phosphorylation 
(Wernimont et al., 2010, 2011). A quantitative phosphopro-
teome study revealed 156 phosphorylation sites that are 
differentially phosphorylated between WT and TgCDPK3 
mutant parasites (Treeck et al., 2014). The TgCDPK3-
dependent phosphoproteome includes phosphorylation 
sites on proteins involved in parasite motility, such as the 
cyclase-associated protein and myosin A (Myo A), but also, 
and perhaps surprisingly, those involved in metabolic pro-
cesses such as the α-ketoacid dehydrogenase (BCKDH) 
subunit, E1α, required for the breakdown of branched-chain 
amino acids (BCAAs) and conversion of pyruvate to the 
TCA driver acetyl-CoA (MacRae et al., 2012; Oppenheim 
et al., 2014). The link to proteins not obviously involved in 
egress and motility, as well as changes in the phosphopro-
teome regardless of the presence of ionophore, suggests 
that TgCDPK3 function extends beyond egress.
The phosphorylation site that appeared to have 
one of the most marked reductions in phosphoryla-
tion state in TgCDPK3 mutants compared to WT para-
sites (Treeck et al., 2014), is situated within a putative 
transporter of the MFS family (TGGT1_257530, 
named ApiAT5-3 as per Parker et al., 2018) that has 
moderate homology to a BCAA transporter. Given the 
additional evidence from the phosphoproteomic data-
set that TgCDPK3 putatively regulates BCAA catab-
olism via BCKDH, we hypothesised that TgCDPK3 
might be involved in BCAA uptake in addition to reg-
ulating motility. Through functional analysis, we show 
that ApiAT5-3 is rapidly phosphorylated at serine 56 
(S56) during the first minute of induced egress. Using 
a conditional KO approach, we show that ApiAT5-3 is 
essential, and that deletion leads to a delayed death 
phenotype that is accompanied by a transcriptional 
response relating to translational stress. Using a 
combination of metabolic analysis and heterologous 
expression in Xenopus laevis oocytes, we confirm 
that ApiAT5-3 transports tyrosine but has only lim-
ited capacity to transport BCAAs. In growth compe-
tition assays performed with parasite lines that rely 
on phosphomutants or phosphomimetics, we show 
that phosphorylation of S56 may be important, but 
not essential, for parasite fitness. However, we could 
not measure significant differences in tyrosine import 
using metabolomic or heterologous expression assays 
of phosphorylation site mutants. This suggests that 
either TgCDPK3-mediated phosphorylation is not 
important for ApiAT5-3 function, or that the effect is 
too subtle to measure and plays a small contribution 
to the phenotypes observed for TgCDPK3 inactivation.
Results
ApiAT5-3 is located at the parasite periphery and 
phosphorylated during ionophore-induced egress in a 
TgCDPK3-dependent manner
ApiAT5-3 was previously identified as phosphorylated at 
serine 56 in a TgCDPK3-dependent manner (Treeck et al., 
2014). BLAST analysis using the Transporter Classification 
Database (https://www.tcdb.org/) predicts that ApiAT5-3 
possesses a modest level of homology to a BCAA trans-
porter. This was interesting, as deletion of TgCDPK3 was 
previously shown to lead to upregulation of the BCKDH 
complex (Treeck et al., 2014), involved in BCAA catabo-
lism. This indicated that TgCDPK3 may directly control 
BCAA transport by phosphorylating ApiAT5-3.
Topology prediction (https://embnet.vital-it.ch/soft-
ware/TMPRED_form.html, Hofmann, 1993) places the 
N-terminal regions of ApiAT5-3 at the luminal side of 
the parasite, potentially allowing for direct interaction 
with TgCDPK3, which also localises to the plasma 
membrane. ApiAT5-3 contains several phosphorylation 
sites at its N-terminus, of which S56 was the only one 
previously identified as being TgCDPK3-dependent 
(Fig. 1A, upper panel). It is entirely plausible, however, 
that kinases other than TgCDPK3 act during egress 
to phosphorylate additional residues on the ApiAT5-3 
N-terminus. To investigate this, we queried a data-
set recently generated in our laboratory in which we 
have quantified, using tandem-mass-tag technology 
(Thompson et al., 2003), phosphorylation site abun-
dance on T. gondii proteins across four time points (0, 
15, 30 and 60 s) following ionophore treatment (Caia 
Dominicus, in preparation). From the ~850 phosphoryla-
tion sites that are phosphorylated or dephosphorylated 
during egress, we identified S56 of ApiAT5-3 as increas-
ingly phosphorylated over time (Fig. 1A, lower panel, 
Table S1). We also identified several proteins already 
known to be more phosphorylated in response to Ca2+ 
signalling including Myosin A, Myosin F and DrpB (Nebl 
et al., 2011; Lourido et al., 2013; Treeck et al., 2014). 
None of the other phosphorylation sites on the ApiAT5-3 
N-terminus increased in phosphorylation state prior to, 
or during egress (Table S1). However, S15 of ApiAT5-3 
was dephosphorylated during ionophore treatment. 
Collectively these data indicate that S56 is phosphor-
ylated in a TgCDPK3-dependent manner upon Ca2+ 
stimulation, and that a phosphatase is acting on S15 
during the same period, while the other phosphorylation 
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sites either remain unaffected or are not detected by the 
assay.
To localise ApiAT5-3 in T. gondii parasites, we intro-
duced an ectopic copy of the apiAT5-3 gene with a 
HA-epitope tag at its C-terminal, into RH ∆hxgprt para-
sites (ApiAT5-3::HA). 1000 bp upstream of the start-ATG 
were used as a predicted promotor to ensure natural 
expression levels. Western blotting confirmed expres-
sion of a 42 kDa protein close to the predicted size 
(56 kDa) (Fig. 1B). Immunofluorescence assays (IFA) 
showed ApiAT5-3 at the periphery of the parasite, co-lo-
calising with SAG1 that resides at the plasma mem-
brane (Fig. 1C). No ApiAT5-3::HA could be detected in 
nascent daughter cells, a hallmark of most inner mem-
brane complex proteins. Together, these data suggest 
that ApiAT5-3 localises, like TgCDPK3, to the plasma 
membrane, and thus, could be a bona fide target of 
TgCDPK3 in vivo.
apiAT5-3 deletion causes delayed parasite death
ApiAT5-3 depletion is predicted to have a high fitness 
cost (Toxo DB 7.1 [Sidik, Huet, et al., 2016]). Accordingly, 
we generated a conditional KO using the dimerisable cre 
recombinase (DiCre) strategy. We replaced the endog-
enous copy of apiAT5-3 with a recodonised version in 
RH ∆ku80DiCre parasites, by double homologous recom-
bination, using a double-guide strategy (Long et al., 
2016) (Fig. 2A). We initially placed a loxP site adjacent 
to the Kozac sequence of ApiAT5-3 but were unable to 
obtain correct integration. We hypothesised that the loxP 
sequence might be interfering with promotor elements 
and moved it 100 and 200 bp upstream of the predicted 
start ATG respectively. Both of these constructs correctly 
integrated into the genome. Subsequent analyses were 
performed with the resulting ApiAT5-3_loxP, with the loxP 
at ATG -100bp. Integration was confirmed by PCR ampli-
fication (Fig. 2B, left panel). To test whether ApiAT5-3 is 
Fig. 1. ApiAT5-3 localises to the plasma membrane and is phosphorylated at serine 56 upon ionophore treatment.  
A. Quantification of the phosphorylation state of residues in the ApiAT5-3 N-terminus in TgCDPK3 KOs and during ionophore-induced 
egress (from Treeck et al., 2014). Upper panel: The heatmap shows differential phosphorylation of S56 in TgCDPK3 mutants compared to 
WT parasites, but not any other of the identified phosphorylation sites. Intracellular (IC) and extracellular (EC) parasites with and without 
1 µM ionophore (iono). P-site = phosphorylation site. Numbers represent residue position. Black ‘x’ = phosphorylation site not identified. 
Fold changes are log2. Bottom panel: Change in relative phosphorylation of ApiAT5-3 and proteins with previously described ionophore-
dependent phosphorylation sites, measured after addition of 8 µM ionophore over 60 s. Numbers after the identifier represent the 
phosphorylation site quantified.  
B. ApiAT5-3 was detected by Western blot analysis of ApiAT5-3::HA cell lysate using an anti-HA antibody. Loading control anti-Toxo.  
C. IFA of ApiAT5-3::HA expressing parasites shows that ApiAT5-3 localises to the periphery of the intracellular tachyzoite. Red = HA, Green 
= SAG1, Blue = DAPI. Scale bar 5 µm.
(A) (B)
(C)
4 B. A. Wallbank et al. 
© 2018 The Authors. Molecular Microbiology Published by John Wiley & Sons Ltd, Molecular Microbiology, 0, 1–15
Fig. 2. ApiAT5-3 is essential for parasite proliferation.  
A. Generation of the ApiAT5-3_loxP line using CRIPSPR/Cas9 to increase site-directed integration. Protospacer adjacent motif (PAM) 
indicated by black arrows. Primer pairs represented by coloured triangles.  
B. Left panel: PCR analysis shows correct integration of the ApiAT5-3_loxP construct at both the 3ʹ and 5ʹ ends and a loss of WT apiAT5-3 at 
the endogenous locus. White * = non-specific bands. Right panel: Addition of RAP leads to correct recombination of the loxP sites.  
C. Fluorescent microscopy of ApiAT5-3_loxP parasites 24 h after addition of DMSO or RAP. Scale bar 5 µm.  
D. Plaque assay showing loss of plaquing capacity of ApiAT5-3_loxP parasites upon RAP treatment.  
E. Parasite per vacuole number shown as mean %, n = 3.  
F. Stills from live video microscopy at 36, 42 and 45 h into third lytic cycle post-RAP treatment. Red = RH Tom, dashed white line = intact WT 
ApiAT5-3_loxP vacuoles, green = apiAT5-3 KO. Scale bar 20 µm.  
G. IIE assay showing no significant difference between DMSO- and RAP-treated ApiAT5-3_loxP (at 30 h into lytic cycle 2 post-DMSO/RAP 
treatment). Statistical analysis using multiple comparison two-way ANOVA, n = 2.
(A) (B)
(C) (D)
(E)
(G)
(F)
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an essential gene, we treated parasites for 4 h with either 
rapamycin (RAP) or DMSO. PCR analysis showed a near 
complete excision of the floxed gene (Fig. 2B, right panel). 
Correct excision of the ApiAT5-3 open reading frame 
resulted in YFP positive parasites that could be readily 
distinguished from WT by microscopy (Fig. 2C). Upon 
performing plaque assays it became evident that RAP, 
but not DMSO treatment, resulted in a complete block 
in plaque formation (Fig. 2D). A small number (<0.5%) of 
plaques could be identified in RAP-treated cultures, how-
ever, parasites contained in these plaques where YFP(–), 
indicating that they arose from non-excised parasites 
(data not shown). Over time these non-excised parasites 
within the RAP-treated population outgrew the KOs (Fig. 
S1A), further reinforcing the fact that ApiAT5-3 is essential 
for parasite survival under these experimental conditions. 
These non-excising parasites (termed ApiAT5-3_loxPd-
DiCre) were isolated and, even on the addition of subse-
quent RAP, did not lose their endogenous copy of the 
gene (Fig. S1B). These ApiAT5-3_loxPdDicre, which pre-
sumably possess a non-functioning diCre recombinase, 
were used as controls for subsequent experiments, as 
detailed below. In an attempt to isolate apiAT5-3 KOs 
and generate stable ∆apiAT5-3 lines, YFP (+) parasites 
were sorted by flow cytometry. However, neither sorting 
for a population of excised, YFP (+) parasites using flu-
orescence-activated cell sorting (FACS), nor single-cell 
cloning by limiting dilution after RAP-mediated excision, 
resulted in viable parasites. Although small plaques in 
cloning plates were initially visible under the microscope 
after 9 days (Fig. S1C), they did not grow any further, 
suggesting that apiAT5-3 KO leads to eventual parasite 
death rather than a maintenance of growth at low levels.
To visualise at which time points ApiAT5-3 is important, 
we followed replication of live RAP-treated ApiAT5-3_loxP 
parasites over three lytic cycles, where each lytic cycle is 
defined as growth over 36 h, before passage into a fresh 
culture dish containing host cells. This analysis revealed 
that in the first cycle, RAP-treated (apiAT5-3 KO) para-
site numbers and replication rate remained comparable 
to DMSO-treated (WT) parasites (Fig. 2E). However, by 
36 h into the second replicative cycle there was a 60.7% 
decrease in the number of vacuoles with more than 16 
parasites compared to the DMSO control. By the end 
of the third cycle the apiAT5-3 KO parasites consisted 
largely of two or fewer parasites/vacuole, even after the 
WT had successfully egressed (48 h into cycle). To better 
identify phenotypic consequences of apiAT5-3 deletion, 
we followed replication over time using live-video micros-
copy. We started recording 29 h into the third lytic cycle 
post-RAP treatment, by which time apiAT5-3 KO para-
sites display a marked growth defect. To facilitate a more 
accurate comparison between apiAT5-3 KO and WT 
parasites, tdTomato expressing RH parasites (RH Tom) 
were spiked into the imaging wells at a 1:1 ratio. These 
analyses revealed that apiAT5-3 KO does not lead to 
early egress. However, in the subsequent parasite cycle 
parasites that invade often do not proceed beyond two 
parasites/ vacuole (Fig. 2F, Movies S1A and B).
As we showed that ApiAT5-3 is phosphorylated directly 
after ionophore treatment (Fig. 1A), we postulated that it 
may be required for IIE. To assess this, we performed egress 
assays of the DMSO- and RAP-treated lines in the presence 
of 8 µM Ca2+
 ionophore. However, there was no significant 
difference between the KO and WT (Fig. 2G) suggesting that 
phosphorylation of ApiAT5-3, in response to elevated Ca2+ 
levels, plays a role in processes other than egress.
apiAT5-3 deletion causes upregulation of genes 
encoding for ribosome subunits, but not alternative 
transporters
Deletion of a transporter may lead to upregulation of 
alternative transporters or may manifest as a stress 
response that carries a detectable signature. To inves-
tigate this, we measured transcript levels using RNA-
seq, comparing RAP-treated ApiAT5-3_loxP with 
ApiAT5-3_loxPdDiCre parasites, which, as mentioned 
previously, do not excise the endogenous locus, even 
when treated with RAP (Fig. S1B). RNA was isolated 
in biological triplicate at 4 h post-RAP treatment, the 
time point at which we did not expect to see major 
changes in the transcriptome, and 60 h post-treatment, 
by which time point the RAP-treated ApiAT5-3_loxP 
parasites are still viable but start to display a growth 
defect. Indeed, at 4 h transcripts from the apiAT5-3 
gene were only slightly reduced in the RAP-treated 
ApiAT5-3_loxP parasites compared to the RAP-treated 
ApiAT5-3_loxPdDiCre parasites (17.1%). In contrast, 
at 60 h post-RAP treatment, a 64.7% reduction was 
observed (Fig. 3A). Unexpectedly, only 435 transcripts 
showed a statistically significant differential expression 
between the WT and apiAT5-3 KO parasites at the 60 h 
time point, compared to the 4 h time point, indicating a 
modest transcriptional response to apiAT5-3 deletion 
(Fig. 3B). GO-term analysis of the differentially tran-
scribed genes showed most enrichment (5.41-fold) for 
genes important for translation. Among this enriched 
group, these genes encode almost exclusively genes 
for ribosomal proteins (Fig. 3C, Table S2). No single 
transporter was specifically upregulated, indicating 
that there is no rapid transcriptional compensation 
when apiAT5-3 is deleted.
Collectively these data show that ApiAT5-3 is an essen-
tial protein that is required for intracellular replication. Its 
depletion leads to a complete arrest in growth which is 
not accompanied by a substantial stress response, but 
rather modest signs of translational stress.
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Mutation of S56 to alanine, but not a phosphomimetic 
leads to a reduction in fitness
Having established that ApiAT5-3 is essential for the lytic 
cycle, we next sought to examine the role of TgCDPK3-
mediated phosphorylation in ApiAT5-3 function. To do 
this, we complemented ApiAT5-3_loxP parasites with 
either WT ApiAT5-3, or variants where S56 is mutated 
to alanine (S56A) or to aspartic acid (S56D). To prevent 
possible differences in growth between the parasite 
lines due to differential expression of the complemen-
tation constructs, we inserted each into the uprt locus 
by double homologous recombination, under control of 
the endogenous promoter (Fig. 4A). Complementation 
into the uprt locus was verified by PCR (Fig. 4B). The 
complementation constructs also carried a C-terminal 
HA epitope tag to verify correct trafficking to the plasma 
membrane. Immunofluorescence displayed correct traf-
ficking in all variants (Fig. 4C).
To compare fitness between the WT, the phos-
phomimetic (S56D) and the phosphomutant (S56A) 
complemented lines in the absence of apiAT5-3, we 
deleted the endogenous copy using RAP treatment. 
This results in parasite strains that solely rely on the 
complemented copy of the gene. We confirmed correct 
excision of apiAT5-3 by virtue of YFP expression post-
RAP treatment (Fig. 4C) and PCR analysis (Fig. S2A). 
To ensure protein levels of the complemented genes 
were comparable, we attempted to quantify protein lev-
els of the ∆apiAT5-3ApiAT5-3, ∆apiAT5-3ApiAT5-3_S56A and 
∆apiAT5-3ApiAT5-3_S56D lines by Western blot. However, 
despite several attempts, we failed to visualise the 
complemented proteins. As an alternative approach, 
we sought to quantify the protein levels using fluores-
cent anti-HA antibodies and analysis by flow cytome-
try. Comparison of the geometric mean of fluorescence 
indicated that the amount of ApiAT5-3, ApiAT5-3_S56A 
Fig. 3. ∆apiAT5-3 parasites display a transcriptional response related to amino acid starvation.  
A. Extracted reads for recodonised apiAT5-3 from RNA sequence data show a significant reduction of apiAT5-3 transcripts in RAP-treated 
ApiAT5-3_loxP lines 60 h post-RAP treatment compared to RAP-treated ApiAT5-3_loxPdDiCre parasites.  
B. Heatmap of genes that change significantly (adjusted p < 0.05) in transcript read number between WT and ∆apiAT5-3 60 h post-addition 
of RAP.  
C. Gene ontology term enrichment shows that genes involved in translation processes are significantly enriched among the differentially 
expressed genes 60 h post-RAP treatment.
(A)
(C)
(B)
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or ApiAT5-3_S56D protein did not differ significantly 
between the complemented lines (Fig. 4D). This would 
suggest that any subsequent phenotypes were a result 
of mutation of the S56 phosphorylation site and not dif-
fering apiAT5-3 expression levels. RAP-treated parasite 
lines were viable and allowed us to isolate clones by 
limiting dilution, all of which restored growth in plaque 
assays (Fig. S2B). This shows that (i) complementation 
of apiAT5-3 by expression at the uprt locus fully restores 
ApiAT5-3 function and (ii) that neither the introduction 
of phosphomimetics nor phosphomutants of S56 are 
lethal to parasite growth. This is not surprising as dele-
tion of TgCDPK3, the kinase putatively responsible for 
ApiAT5-3 phosphorylation during egress, does not lead 
to a severe growth phenotype. Accordingly, phosphomu-
tants would not be expected to display drastic differ-
ences in growth. We therefore performed competition 
assays in which we compared growth of YFP expressing 
Fig. 4. ∆apiAT5-3ApiAT5-3_S56A demonstrates a fitness defect.  
A. Generation of the ApiAT5-3ApiAT5-3/_S56A/_S56D complementation lines. PAM indicated by black arrow. Primer pairs represented by coloured 
triangles.  
B. PCR analysis shows correct integration of the ApiAT5-3_loxP construct at both the 3ʹ and 5ʹ ends and a loss of uprt. White * = nonspecific 
band.  
C. IFA of ApiAT5-3ApiAT5-3/_S56A/_S56D::HA expressing parasites shows that ApiAT5-3 is correctly trafficked to the periphery of the intracellular 
tachyzoite in both the presence (DMSO) and absence (RAP) of the endogenous apiAT5-3. Red = HA. Green = YFP, indicating correct 
excision of the endogenous apiAT5-3. Scale bar 10 µm.  
D. Geometric mean of red fluorescence calculated by flow cytometric analysis of complemented parasites, probed with red fluorescent anti-
HA antibody. Statistical analysis carried out using multiple comparison, two-way ANOVA, ns = not significant. All complemented lines differ 
significantly in mean fluorescence from ApiAT5-3_loxP (p < 0.0001), n = 3.  
E. Growth competition assay by flow cytometry shows that ∆apiAT5-3ApiAT5-3_S56A parasite growth is reduced relative to the non-excised 
ApiAT5-3ApiAT5-3_S56A line. Statistical analysis using multiple comparison, two-way ANOVA of mean ratio to day 0 normalised to 1. 
***p < 0.001, n = 3.
(A)
(D)
(B)
(C)
(E)
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complementation lines that fully rely on the complemen-
tation variant for growth (∆apiAT5-3ApiAT5-3/S56A/S56D) 
mixed in a 1:1 ratio with their non-excised, colourless 
counterpart (ApiAT5-3ApiAT5-3/S56A/S56D). Using the ratio 
of 4’,6-diamidino-2-phenylindole (DAPI)-stained para-
sites (DAPI labels the DNA of all parasites) and YFP 
expressing parasites (YFP is expressed only in the com-
plementation lines), we followed growth over 14 days in 
biological triplicates. While ∆apiAT5-3ApiAT5-3 parasites 
showed no difference in growth compared to their WT 
control, ∆apiAT5-3ApiAT5-3_S56A was reduced by 84.0% 
after 14 days (Fig. 4E). Strikingly, ∆apiAT5-3ApiAT5-3_S56D 
was not outcompeted and grew at similar levels to the 
WT control.
Collectively these data indicate that phosphorylation 
of S56 while not essential is important for intracellular 
growth. However, we cannot exclude that mutating S56 to 
an alanine impacts protein function by other means than 
mimicking non-phosphorylated S56.
ApiAT5-3 is a primary transporter of tyrosine, but not 
branched-chain amino acids
The predicted homology of ApiAT5-3 to a BCAA trans-
porter and the profound upregulation of the BCKDH 
complex in ∆cdpk3 parasites suggested a direct role for 
ApiAT5-3 in BCAA transport. To test this, we expressed 
apiAT5-3 in the heterologous expression system, X. lae-
vis oocytes. Concurrently with our study, data were pre-
sented that ApiAT5-3 may be a tyrosine transporter (Giel 
van Dooren, personal communication and pre-published 
in BioRx [Parker et al., 2018]). We, therefore, tested BCAA 
import and replicated the tyrosine uptake capacity of 
ApiAT5-3 in oocytes expressing WT ApiAT5-3 (Fig. 5A). 
Measuring unidirectional influx, we observed a signif-
icant (4.0-fold) increase in the uptake of 14C-tyrosine 
into ApiAT5-3-expressing oocytes compared to either 
water-injected or uninjected control oocytes under the 
conditions tested, consistent with results from (Parker 
Fig. 5. Functional analysis of the ApiAT5-3 transporter.  
A. X. laevis oocytes expressing ApiAT5-3 demonstrate a significant increase in 14C-L-tyrosine uptake. Ten oocytes per experiment. 
Analysis carried out using a two-tailed, paired, Student’s t-test. ***p < 0.001 Box plots show mean, first and third quartile and SD, n = 5. 
B. Extracellular, RAP-treated, ApiAT5-3_loxP tachyzoites, labelled with 13C-L-tyrosine or 13C-L-isoleucine, display a marked decrease in 
tyrosine but not isoleucine import, relative to WT, n = 2.  
C. Plaque assay shows no rescue of growth of RAP-treated ApiAT5-3_loxP on addition of excess (2 mM) L-tyrosine.
(A)
(C)
(B)
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et al., 2018). We also observed moderate ApiAT5-3-
dependent phenylalanine influx, but not for the BCAA 
valine (Fig. S3A), suggesting that, while ApiAT5-3 is 
capable of tyrosine transport, it is unlikely to be a major 
BCAA transporter.
To verify the role of ApiAT5-3 in tyrosine transport in 
our conditional KO parasites, we measured intracellu-
lar 13C-tyrosine levels in RAP-treated ∆apiAT5-3ApiAT5-3 
(WT) and ApiAT5-3_loxP (KO) parasites (74 h post-exci-
sion), after 1 h in the presence of growth media containing 
13C-tyrosine. In an analogous manner, we also mea-
sured 13C-isoleucine uptake in order to verify if ApiAT5-3 
is also a BCAA transporter. ∆apiAT5-3ApiAT5-3 was used 
instead of DMSO-treated ApiAT5-3_loxP to control for 
any potential effects of RAP on parasite metabolism. 
This analysis verified a reduction of 13C-labelled tyrosine 
uptake (40.5% compared to ∆apiAT5-3ApiAT5-3), but not 
isoleucine uptake (4.3% compared to ∆apiAT5-3ApiAT5-3) 
(Fig. 5B). We also measured the intracellular abun-
dance of all detectable amino acids when labelling with 
13C-tyrosine. We observed a reduction of intracellular 
tyrosine abundance (63.2%) in the apiAT5-3 KO cells 
(as expected), but not phenylalanine which was slightly 
increased in relative abundance (17.45%), suggesting 
that while ApiAT5-3 is able to transport phenylalanine 
in oocytes, it is not the major phenylalanine transporter 
in T. gondii (Fig. S3B). It is important to note that our 
metabolome analysis was performed at the end of cycle 
2 after RAP treatment, when RAP-treated apiAT5-3_
loxP parasites are still viable but start to display a reduc-
tion of growth (Fig. 2E). Therefore, we predict that low 
levels of ApiAT5-3 present at this stage are responsi-
ble for the residual transport of tyrosine. Interestingly, 
we also observed a reduction in intracellular aspartate 
(38.5%) and glycine (28.3%) in apiAT5-3 KO cells (Fig. 
S3B). Since T. gondii is not known to be auxotrophic for 
these amino acids, we reasoned that the observed death 
phenotype is unlikely caused by a defect in glycine or 
aspartate import, and instead focused our subsequent 
analysis on tyrosine. We also observed an increase in 
the abundance of glutamine, valine, isoleucine and pro-
line, indicating potential wider metabolic effects.
To test whether exogenous tyrosine can complement 
the loss of ApiAT5-3, we grew parasites in media with 5× 
the normal amount of tyrosine (2 mM). However, plaque 
assays revealed that RAP-treated ApiAT5-3_loxP parasite 
growth was not restored (Fig. 5C). Several attempts were 
also made to isolate stable ∆apiAT5-3 clonal lines by lim-
iting dilution in the presence of 2 mM tyrosine. Again how-
ever, this was unsuccessful as parasites appeared to die 
after several rounds of replication, much like those grown 
in normal media. In other organisms, phenylalanine can 
be converted into tyrosine. Therefore, we tested whether 
phenylalanine supplementation (2 mM) can rescue the 
growth phenotype of apiAT5-3 KO parasites. No growth 
rescue could be observed (Fig. S3D). Together, these 
results suggest that ApiAT5-3 is the only transporter of 
tyrosine in T. gondii and that phenylalanine cannot be 
readily converted into tyrosine in T. gondii parasites.
As ApiAT5-3 is phosphorylated during egress in a 
TgCDPK3-dependent manner, and as S56 phosphomu-
tants display a moderate fitness cost, we postulated a 
functional link between S56 phosphorylation and tyro-
sine import. We, therefore, tested uptake of isotopically 
labelled tyrosine by extracellular ∆apiAT5-3ApiAT5-3_S56A
 
and ∆apiAT5-3ApiAT5-3_S56D phosphomutant strains. No 
statistically significant difference in tyrosine import was 
observed in these assays (Fig. S3E) either because 
phosphorylation of S56 plays no role in tyrosine import, 
or because the effect of phosphomutations on tyrosine 
import at the parasite level is subtle. Therefore, we also 
assessed differences in tyrosine uptake in X. laevis 
oocytes heterologously expressing ApiAT5-3_S56A and 
ApiAT5-3_S56D. As it has not been determined whether 
the S56 residue is phosphorylated in situ by native 
oocyte kinases, it is difficult to determine the exact role 
of phosphorylation in the tyrosine transport function of 
ApiAT5-3 expressing oocytes. However, comparison 
between S56A phospho-null to S56D phosphomimic 
expressing oocytes could provide a good indication 
as to the functional relevance of this residue. Although 
ApiAT5-3_S56A-expressing oocytes displayed a trend 
towards a reduction in tyrosine uptake (average 19.5% 
reduction in S56A relative to WT ApiAT5-3-expressing 
oocytes), this difference was not statistically significant 
(Fig. S3F). The S56D expressing oocytes display a mar-
ginal increase in tyrosine uptake of 14.0% that again 
was not statistically significant. Collectively these data 
indicate that ApiAT5-3 is a primary tyrosine transporter 
and that S56 phosphorylation plays only a minor, if any, 
role in tyrosine import.
Discussion
TgCDPK3 has previously been implicated in controlling 
distinct biological processes such as gliding motility 
and metabolism. How these are linked, however, has 
been unclear. Mutants that display only IIE and IID phe-
notypes have been identified (Black et al., 2000; Gaji et 
al., 2015), arguing that TgCDPK3 may be an upstream 
regulator of both processes. Here we show that upon 
activation by the Ca2+ ionophore A23187, TgCDPK3 
leads to an increase in ApiAT5-3 phosphorylation at 
S56. This occurs at the same time, and to a similar inten-
sity, as other previously identified targets of TgCDPK3 
(e.g. serine 21/22 of MyoA) and other kinases involved 
in signalling (e.g. TgCDPK1). MyoA and ApiAT5-3 are 
both located at, or close to, the plasma membrane. It 
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is conceivable that, upon activation, TgCDPK3 phos-
phorylates proteins at the plasma membrane, some of 
which are important for motility and others (e.g. trans-
porters) that prepare the parasite for the extracellular 
milieu. In this study, we demonstrate that the S56 res-
idue becomes rapidly phosphorylated prior to egress 
in a TgCDPK3-dependent manner. However, the timing 
of phosphorylation during egress does not appear to 
be linked to the phenotype of the ApiAT5-3 KO, which 
stalls growth after invasion of the host cell. The tim-
ing of phosphorylation during egress and an appar-
ent role of the transporter during intracellular growth 
could be explained that phosphorylation prepares the 
parasite for the extracellular milieu, or for reinvasion. 
Interestingly, ApiAT5-3 possesses several other phos-
phorylation sites in its N-terminus, aside from S56, that 
either do not change in phosphorylation state or, in the 
case of S15, appear dephosphorylated during induced 
Ca2+ signalling. How S15 dephosphorylation and S56 
phosphorylation are controlling ApiAT5-3 function 
requires further investigation, however it is evident 
that mutating S56 to a non-phosphorylatable residue 
markedly reduces parasite fitness, similar to the growth 
defect observed for TgCDPK3 mutants (McCoy et al., 
2012). Phosphorylation of transporters has been shown 
to regulate affinity, specificity and flux of cargo (Liu and 
Tsay, 2003; Lee et al., 2007; Ramamoorthy et al., 2010; 
Tamura et al., 2013; Jang et al., 2014; Aryal et al., 2015). 
Accordingly, the observed fitness cost in S56A mutants 
could be indicative of a reduction in tyrosine import, 
for which the parasite is auxotrophic (Marino and 
Boothroyd, 2017). It appears that deletion of ApiAT5-3 
has little effect during the first two lytic cycles of divi-
sion, indicating that relatively normal growth rates can 
be sustained with lower ApiAT5-3 levels. A critical point 
is reached between the second and third lytic cycles, 
when parasites are still able to egress, but then fail to 
develop beyond two parasites/vacuole in most cases. 
Whether this is because ApiAT5-3 function is critically 
important shortly after invasion, or whether this is the 
point at which ApiAT5-3 protein levels are diluted below 
a critical concentration is not known and further work 
will be required to answer this question.
While we observed a clear role for ApiAT5-3 in tyrosine 
transport, expression of the ApiAT5_S56A phosphomu-
tant did not lead to significant changes in tyrosine import 
in Toxoplasma parasites or in Xenopus oocytes. Although 
a small reduction in tyrosine import was observed in 
Xenopus oocytes expressing ApiAT5-3_S56A, the differ-
ence is subtle and could be the result of small differences 
in expression levels or phosphorylation state of ApiAT5-3 
in oocytes. Thus, the oocyte assays did not allow us to 
draw conclusions on the effect of S56 phosphorylation, 
apart from that it appears not to be a prerequisite for 
tyrosine import in T. gondii. Whether or not S56 phos-
phorylation plays a minor role in regulating ApiAT5-3 can-
not be answered at this stage. Growth competition assays 
showed that a phosphomimetic mutant gives parasites a 
competitive growth benefit. While this could be a result of 
changing a functionally important residue to a non-related 
amino acid, it could also be that phosphorylation of S56 
plays a small role in ApiAT5-3 regulation. We observed 
a 84.0% reduction in growth of ∆apiAT5-3ApiAT5-3_S56A 
mutants compared to WT parasites over 14 days. This 
translates into a reduced replication rate of 6.74% per 
24 h. If this growth defect is a direct result of reduced tyro-
sine import, we would predict that there only be a 0.56% 
reduction in import during the 1 h period in which the 
13C-tyrosine uptake assays are performed. This difference 
would be too small to measure with the methods avail-
able. The observation that tyrosine transport by ApiAT5-3 
appears only marginally affected by TgCDPK3 activity, 
leaves open the question as to how TgCDPK3 is linked to 
the changes observed on the phosphoproteome of meta-
bolic enzymes in TgCDPK3 mutants (Treeck et al., 2014). 
Further work is required to answer this question.
Apart from regulating amino acid transport, phosphory-
lation of transporters has also been shown to regulate traf-
ficking to the surface (Nissen-Meyer et al., 2011; Rice et al., 
2012; Abramian et al., 2014). However, a role for S56 in traf-
ficking is less likely for two reasons: (i) we did not observe 
any obvious defects in surface translocation of the trans-
porter in parasites and (ii) TgCDPK3 phosphorylates S56 
shortly before, or during egress, at which state the trans-
porter is already on the surface. If S56 phosphorylation was 
important for surface translocation, we would expect this 
to occur at an earlier stage. However, we cannot exclude 
the possibility that minor differences in trafficking capacity 
impact tyrosine transport, resulting in the growth phenotype.
Interestingly, we haven’t been able to rescue the effect 
of apiAT5-3 loss in our conditional KO parasites through 
growth in high tyrosine concentrations. These results 
differ from those in Parker et al. whereby growth can, 
at least partially, be rescued in high tyrosine medium 
(Parker et al., 2018). One mechanism to counter low 
tyrosine levels that most organisms possess, is the abil-
ity to convert phenylalanine into tyrosine, via the enzyme 
phenylalanine-4-hydroxylase (AAH). However, the inabil-
ity to overcome the tyrosine import-related growth defect 
in ApiAT5-3 conditional KOs through addition of exog-
enous phenylalanine, indicates that this pathway is not 
available. Indeed, both isoforms of AAH (AAH1 and 
AAH2) have recently been shown to be secreted into the 
host cell during Toxoplasma infection, where they would 
be unable to rescue a tyrosine transporter defect in the 
plasma membrane (Marino and Boothroyd, 2017; Wang 
et al., 2017). Another explanation as to why Parker et 
al. have successfully rescued the effects of apiAP5-3 
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deletion through addition of excess tyrosine, could be 
via the upregulation of alternative transporters. Although 
a small amount of tyrosine appears to be imported in 
our apiAT5-3 KO line (Fig. 5B), this is likely due to the 
presence of residual ApiAT5-3 protein in the plasma 
membrane after RAP treatment. Along with our inability 
to rescue growth upon tyrosine supplementation, we con-
clude that this residual tyrosine import is unlikely due to an 
alternative transporter. Further to this, our transcriptomic 
analysis argues against a rapid sensing and transcriptional 
compensation for the lack of tyrosine import, so if upreg-
ulation of alternative transporters occurs, it will be a slow 
process. Another explanation may be that slight differences 
in the genetic background or passage history, and potential 
epigenetic changes in the parental strains, leads to a dif-
ference in capacity for amino acid transport. There is some 
indication that this may be the case as, in our metabolo-
mics experiments, the ApiAT5-3 deletion showed reduced 
levels of glycine and aspartic acid in addition to tyrosine, 
while in Parker et al., other amino acids were observed to 
be less abundant in addition to tyrosine. We also saw an 
increase in abundance of some amino acids that differ from 
Parker et al. It may be interesting in the future, to compare 
our apiAT5-3 KO with that of Parker et al., and identify any 
compensatory mechanisms the parasites can use to adjust 
to tyrosine starvation. Interestingly, deletion of apiAT5-3 
leads to a growth arrest that is not accompanied by major 
transcriptional responses, but upregulation of most tran-
scripts for ribosomal subunits, which indicate translational 
changes in response to tyrosine depletion. We have not 
further pursued this response in this study, but it is remi-
niscent of the hibernation state in Plasmodium falciparum, 
whereby depletion of isoleucine, an essential amino acid for 
this parasite, leads to arrest in growth by translational arrest 
without a major stress response (Babbitt et al., 2012). This 
would suggest that translational arrest may be a common 
response among apicomplexan parasites during amino 
acid starvation.
In summary, we show that ApiAT5-3, a novel T. gon-
dii tyrosine transporter, is rapidly phosphorylated in a 
TgCDPK3-dependent manner at S56 prior to, and during 
egress from the host cell. This TgCDPK3-dependent 
phosphorylation at S56 appears important for parasite 
fitness based on phosphomimetics and phosphomutants. 
These results, together with previous studies, support the 
notion that TgCDPK3 simultaneously targets several pro-
teins in, or at, the plasma membrane that are implicated in 
divergent biological processes, such as motility and nutri-
ent homeostasis. If the phosphorylation sites that depend 
on TgCDPK3 function each play a small functional role 
in T. gondii biology, as implicated for S56 on ApiAT5-3, 
the phenotypes observed in ∆cdpk3 parasites may be an 
accumulation of effects on various proteins, which is likely 
true for other kinases as well.
Experimental procedures
Parasite culture
T. gondii parasites were cultured in a confluent mono-
layer of human foreskin fibroblasts (HFFs) maintained in 
Dulbecco’s Modified Eagle Medium (DMEM), GlutaMAX 
supplemented with 10% foetal bovine serum, at 37°C 
and 5% CO2.
Plasmid and parasite strain generation
A comprehensive list of primers and parasite lines used 
throughout this study are described in Tables S3 and S4 
respectively. To generate the epitope tagged ApiAT5-3::HA 
line, the apiAT5-3 gene and associated 5ʹ UTR were PCR-
amplified from RH T. gondii gDNA using the primers 1 and 
2 and cloned using Gibson assembly (Gibson et al., 2008) 
into pGRA::HA::HPT (Saeij et al., 2006), linearised with 
HindIII and NcoI. 25 µg of the pGRA::ApiAT5-3::HA vector 
was transfected into RH ∆hxgprt parasites as previously 
described (Soldati and Boothroyd, 1993). 16–20 h after 
transfection, transgenic parasites were selected using 
25 µM mycophenolic acid (MPA) and 50 µg/ml xanthine 
(XAN). To generate the ApiAT5-3_loxP conditional KO 
lines, the apiAT5-3 5ʹ UTR was first PCR-amplified from 
gDNA with primers 3 and 4. This PCR product was inserted, 
along with the synthetic DNA constructs loxP_apiAT5-3_
loxP_yfp and loxP(-100)_apiAT5-3 (see Table S3 for full 
sequences), by Gibson assembly into pG140::Actin::YFP 
(Andenmatten et al., 2013) that had been PCR-amplified 
using primers 5 and 6 to remove the actin gene. Two micro-
gram of the subsequent pG140::ApiAT5-3_loxP::YFP plas-
mid was linearised with ScaI and co-transfected into RH 
∆ku80∆hxgprt with pSag1::Cas9-U6::dbl-sgApiAT5-3, in a 
molar ratio of 1:10. The pSag1::Cas9-U6::dbl-sgApiAT5-3 
vector was generated by PCR amplification of the pSag1::-
Cas9-U6 (Shen et al., 2014) vector using primers 7 and 
8 to insert the 5ʹ gRNA (gRNA 1) and 9 and 8 to insert 
the 3ʹ gRNA (gRNA 2), prior to re-ligation with T4 DNA 
Ligase (New England Biolabs, Ipswich, MA, USA). gRNA 
1 was then amplified using primers 10 and 11 and Gibson 
cloned into the pSag1::Cas9-U6::sg2ApiAT5-3 that had 
been linearised with KpnI and XhoI as per (Long et al., 
2016). Transgenic parasites were selected using MPA/
XAN as described for pGRA::ApiAT5-3::HA. 5ʹ and 3ʹ inte-
gration was confirmed using primer pairs 12 and 13, and 
14 and 15 respectively. Absence of WT apiAT5-3 was con-
firmed using primers 16 and 17. DiCre-mediated apiAT5-
3 excision was induced with the addition of 50 nM RAP 
to ApiAT5-3_loxP parasites for 4 h. Excision was con-
firmed using primers 13 and 16. To introduce an ectopic 
copy of apiAT5-3 into the uprt gene locus, the apiAT5-3 
gene, and associated 5ʹ UTR, were PCR-amplified from 
gDNA using primers 18 and 19 which was then inserted 
into the BamHI/ PacI digested pUPRT::DHFR-D vec-
tor (Addgene plasmid #58258 [Shen et al., 2014]) using 
Gibson assembly. To generate the pUPRT::ApiAT5-3_
S56A::HA and pUPRT::ApiAT5-3_S56D::HA vectors, 
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the pUPRT::ApiAT5-3::HA vector was modified by site 
directed mutagenesis using the primers 20 and 21 (S56A) 
or 22 (S56D). pUPRT::ApiAT5-3::HA, pUPRT::ApiAT5-3_
S56A::HA and pUPRT::ApiAT5-3_S56D::HA were lin-
earised with PciI prior to the co-transfection of 2 µg into RH 
∆ku80∆hxgprt ApiAT5-3_loxP with pSag1::Cas9-U6::s-
gUPRT (Addgene plasmid #54467 [Shen et al., 2014]) in 
a molar ratio of 1:10. Transgenic parasites were selected 
by the addition of 5 µM 5’-fluo-2’-deoxyuridine to culture 
medium, 16–20 h post-transfection. Integration into the 
genome was confirmed using primer pairs 23 and 24, and 
25 and 26 respectively. Absence of uprt was confirmed 
using primers 27 and 28.
Western blotting and immunofluorescent imaging
For Western blot analysis, intracellular parasites were 
lysed in Laemmli buffer (60 mM Tris-HCl pH6.8, 1% SDS, 
5% glycerol, 5% b-mercaptoethanol, 0.01% bromophenol 
blue) and heated to 37°C for 30 min prior to separation 
on a 10% sodium dodecyl-polyacrylamide gel. Proteins 
were transferred onto a nitrocellulose membrane prior 
to blocking in 3% milk, 0.1% Tween-20 PBS. HA-tagged 
ApiAT5-3 was detected using rat anti-HA (1:500), fol-
lowed by goat anti-rat LI-COR secondary antibody 
(1:1500) and visualised with a LI-COR Odyssey scanner. 
Loading control visualised with Abcam mouse anti-Toxo 
(1:1000), followed by goat anti-mouse LI-COR secondary 
antibody (1:1500).
IFA’s were performed on intracellular parasites grown 
in HFFs on glass coverslips. 1 × 105 parasites were 
seeded 24 h prior to fixation with 3% formaldehyde (FA). 
PBS 0.1% Triton X-100 was added to the fixed cells for 
10 min prior to blocking with 3% bovine serum albumin 
in PBS for 1 h. ApiAT5-3::HA was visualised using rat 
anti-HA (1:500) followed by addition of Alexa594 conju-
gated donkey anti-rat secondary antibody (1:2000). SAG1 
visualised with mouse anti-SAG1 (1:1000) and Alexa488 
conjugated donkey anti-rat secondary antibody (1:2000). 
DAPI, 5 µg/ml.
Plaque assay and amino acid complementation
For plaque assay analysis, 150 parasites were seeded 
on confluent HFF monolayers, grown in 24-well plates, 
and left undisturbed for 5 days, before fixing with chilled 
methanol and staining with 0.1% crystal violet. To assess 
growth in excess tyrosine, plaque assays were repeated 
either at normal tyrosine levels (400 µM L-tyrosine diso-
dium salt; as per Gibco manufacturer) or in DMEM sup-
plemented with 2 mM L-tyrosine disodium salt (dissolved 
for 1 h at 50°C). To ensure tyrosine had successfully dis-
solved samples of the media were analysed by GC-MS 
as previously described (MacRae et al., 2012).
Replication assay
2 × 104 ApiAT5-3_loxP parasites were seeded in tripli-
cate on confluent HFFs in both culture flasks and glass 
bottom 8-well imaging plates and left to invade for 1 h 
prior to treatment with 50 nM RAP or equivalent volume 
DMSO, for 4 h. Parasites were imaged at 24, 36 and/or 
48 h and split at 36 h into new flasks and imaging wells 
for the subsequent replication cycle. At each time point 
parasites were fixed in 3% FA and imaged on a Nikon 
Eclipse Ti-U inverted fluorescent microscope. Parasites/
vacuole were counted manually from five fields of view 
at 20× magnification using the Nikon NIS-Elements 
software.
Live cell microscopy
ApiAT5-3_loxP parasites were treated with RAP or 
DMSO as previously described. Thirty-six hours into 
cycle 2 post-RAP treatment parasites were syringe lysed 
and seeded in glass bottom, 8-well imaging plates in a 
1:1 ratio with RH Tom parasites. After a further 29 h, live 
parasites were imaged on a Nikon Eclipse Ti-U inverted 
fluorescent microscope every 30 min for the next 30 h, in 
a temperature-controlled chamber at 37°C and 5% CO2. 
Images were analysed using the Nikon NIS-Elements 
software.
Ionophore-induced egress assays
ApiAT5-3_loxP parasites were seeded in 96-well imag-
ing plates at a MOI of 0.5, 36 h post-RAP/DMSO treat-
ment. IIE assays were performed in triplicate at 37°C in 
Ringers buffer (155 mM NaCl, 3 mM KCl, 2 mM CaCl2, 
1 mM MgCl2, 3 mM NaH2PO4, 10 mM HEPES, 10 mM 
glucose) 30 h later. The parasites were incubated with 
8 µM Ca2+ ionophore A23187 for 0, 0.5, 1, 1.5, 2, 2.5, 
3, 3.5, 4 and 5 min prior to the addition of 16% FA to a 
final concentration of 3% for 15 min. Wells were subse-
quently washed with PBS and stained with 5 µg/ml DAPI. 
Automated image acquisition of 25 fields per well was 
performed on a Cellomics Array Scan VTI HCS reader 
(Thermo Scientific) using a 20× objective. Image anal-
ysis was performed using the Compartmental Analysis 
BioApplication on HCS Studio (Thermo Scientific).
Competition assays and flow cytometry
For expression analysis of complemented lines, 
syringe lysed ApiAT5-3_loxP, ∆apiAT5-3ApiAT5-3, ∆api-
AT5-3ApiAT5-3_S56A and ∆apiAT5-3ApiAT5-3_S56D lines were 
spun at 72 × g to remove host cell debris for 1 min. The 
supernatant was spun at 2049 × g for 5 min and the pellet 
fixed for 10 min in 3% FA. Fixed parasites were washed in 
PBS and resuspended in 0.1% Triton X-100 for 5 min prior 
to staining with anti-HA conjugated to allophycocyanin 
(1:500) for 1 h. The sample was washed and resuspended 
in PBS before running on a flow cytometer. For compe-
tition assays, 5 × 106 ApiAT5-3ApiAT5-3, ApiAT5-3ApiAT5-3_
S56A
 and ApiAT5-3ApiAT5-3_S56D parasites were mixed in 
a 1:1 ratio with ∆apiAT5-3ApiAT5-3, ∆apiAT5-3ApiAT5-3_S56A 
and ∆apiAT5-3ApiAT5-3_S56D respectively. 5 × 104 parasites 
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were added to fresh HFF monolayers prior to washing and 
fixation, as described previously. After fixation, parasites 
were stained with 5 µg/ml DAPI for 10 min and washed 
and resuspended in PBS before running on a flow cytom-
eter. All parasites were gated on DAPI fluorescence to 
prevent results being skewed by remaining unstained 
host cell debris. The proportion of DAPI (+); YFP (+) (rep-
resenting ∆apiAT5-3ApiAT5-3/S56A/S56D) compared to DAPI 
(+); YFP (–) (representing ApiAT5-3ApiAT5-3/S56A/S56D) was 
calculated. The process was repeated 14 days later for 
comparison to day 0.
Oocyte maintenance and radiotracer uptake assays
ApiAT5-3, ApiAT5-3_S56A and ApiAT5-3_S56D 
were PCR amplified from ∆apiAT5-3ApiAT5-3, ∆api-
AT5-3ApiAT5-3_S56A and ∆apiAT5-3ApiAT5-3_S56D cDNA, 
respectively, using primers 29 and 30 to add a region 
of homology to the XkbN plasmid at the 5ʹ end and a HA 
tag to the 3ʹ end of each gene. These fragments were 
then amplified with primers 31 and 32 to add a 3ʹ XkbN 
homology overhang. These resulting fragments were 
inserted by Gibson assembly into the XkbN1_PfHT (a 
version of pSPGT1 (Woodrow et al., 1999) with a NotI 
site added to the MCS, provided by Ksenija Slavic) 
which had been digested with BglII and NotI, to remove 
the PfHT gene. The resulting XkbN_ApiAT5-3, XkbN_
ApiAT5-3_S56A and XkbN_ApiAT5-3 _S56D plasmids 
were linearised with XbaI for in vitro transcription using 
the Thermo Fisher mMessage mMachine transcrip-
tion kit. Stage V to VI defolliculated X. laevis oocytes 
were obtained commercially (Ecocyte Biosciences) 
for subsequent functional transport studies. Oocytes 
were microinjected with cRNA (20 to 40 ng in 30 nl of 
water) encoding apiAT5-3 template or with a compara-
ble amount of diethylpyrocarbonate-treated water.  The 
oocytes were maintained at 18°C in oocyte Ringer 2 
buffer (82.5 mM NaCl, 2.5 mM KCl, 1.5 mM CaCl2, 1mM 
Na2HPO4, 1 mM MgCl2 and 5 mM HEPES) and used for 
transport studies 72 h after cRNA injection. Transport 
measurements were performed at room temperature on 
groups of 10 oocytes in ND96 medium (96 mM NaCl, 2 
mM KCl, 2 mM CaCl2, 1 mM MgCl2 and 5 mM HEPES) 
containing 1 µM radiolabelled U-14C-L-tyrosine (spe-
cific activity of 486 mCi/mmol; Perkin Elmer), U-14C-
L-phenylalanine (specific activity of 508 mCi/mmol; 
Perkin Elmer) or U-14C-L-valine (specific activity of 271 
mCi/mmol; Perkin Elmer). Transport was measured at 
10 min, over which time uptake of L-tyrosine is linear 
(Parker et al., 2018). Each result was confirmed by at 
least three independent experiments.
Metabolite labelling and extraction
ApiAT5-3_loxP, ∆apiAT5-3ApiAT5-3, ∆apiAT5-3ApiAT5-3_
S56A
 and ∆apiAT5-3ApiAT5-3_S56D parasites were treated 
in triplicate with 50 nM RAP and, at the end of the first 
cycle, seeded in 15 cm culture flasks. Stable isotope 
labelling (1 h) of extracellular parasites with 0.8 mM 
U-13C-L-tyrosine or 4 mM U-13C-L-isoleucine, metabo-
lite extraction and subsequent GC-MS analysis were all 
performed as per (MacRae et al., 2012), on an Agilent 
GC-MSD (7890B-5977A). Data analysis was carried out 
using GAVIN software (Behrends et al., 2011).
RNA sequencing analysis
T. gondii RNA was extracted as per the Qiagen RNA-
easy mini kit user handbook (#74104) from ~5 × 106 
ApiAT5-3_loxP or ApiAT5-3_loxPdDiCre parasites at 0, 4 
and 60 h post-RAP treatment. Analysis was performed 
in triplicate. The FASTQ files were aligned using Bowtie 
2 (Langmead and Salzberg, 2012) to Ensembl Protist 
release 35 of T. gondii (ToxoDB-7.1). They were then 
quantified using RSEM before being processed using 
Bioconducor (Huber et al., 2015). We used DESeq2 (Love 
et al., 2014) to account for gene length and library size, 
and to test for the interaction between treatment and time 
point to generate the differential genelist. We corrected 
for multiple testing using the Benjamini–Hochberg proce-
dure for false discovery rates. To validate the recodonised 
transcript, we both re-aligned to a custom genome rebuilt 
to include the novel sequence, and also used a pseu-
do-alignment approach to quantify purely the reads asso-
ciated with the novel sequence (Bray et al., 2016).
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